Competitor

Jump to

Investing in intellectual property is worth every penny

Intellectual property rights in not a high-profile area among small businesses in India, but SMEs are increasingly understanding the benefits of patent protection
Sun Pharma gains on better outlook for key drug

Analysts expect generic doxycycline to contribute around US$60-80 million in sales in FY14 for Sun Pharma.
Get interviewed on different day than your rival to bag job

Want to land a job? Make sure your strongest competitor is interviewed on a different day! Whether an applicant receives a high or low score may have more to do with who else was interviewed that day than the overall strength of the applicant pool, according to new research.
Sebi chief's blames corp rivalry behind IPO complaints

Sebi chairman UK Sinha today blamed corporate rivalries and vested interests for the complaints the regulator has been getting against certain IPO's. Sinha also warned that obsessive competitive behaviour is hurting the country's interests, report CNBC-TV18.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Competitor

Investing in intellectual property is worth every penny

Sun Pharma gains on better outlook for key drug

Get interviewed on different day than your rival to bag job

Sebi chief's blames corp rivalry behind IPO complaints